Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant

Inclusion Criteria: * Age ≥12 * \<90 days following Allogeneic Transplantation. * ANC\>500/ul for 3 consecutive days. * ≥50% donor cells in all cellular fractions tested. * No active grade II or higher acute graft versus host disease * Receiving ≤ 1 mg/kg/day Methylprednisolone or equivalent * Documentation of morphologic or radiographic remission within 45 days of protocol enrollment Exclusion Criteria: * Patients with acute organ dysfunction requiring monitoring in the Intensive Care unit or receiving invasive interventions that may include, Hemodialysis ,CVVHD, or any form of mechanical ventilation including CPAP/BiPap at the time of starting therapy. * Pregnant or lactating patients and those without a negative pregnancy test. * Patients must have a life expectancy of at least 3 months. * Patients must be HIV negative. * Patients must not be receiving investigational agents for treatment of GVHD. * Patients with severe veno-occlusive disease as determined by standard criteria. * Patients with Type 1 Diabetes at the time of initiation of stem cell transplantation.